ShanTT
Description
The active substance is the Tetanus toxoid adsorbed on Aluminium Phosphate gel. This vaccine is an anti-infectious drug recommended for prevention against tetanus.
Indication:
- Active immunization of children aged 7 years or older and adults
- Active immunization of Pregnant women
- Active immunization of those who are exposed to occupational hazards which make them prone to any kind of injury
Recommended dose is 0.5 ml to be administered via intramuscular route.
Additional information
vaccine-type | Tetanus Toxoid |
---|---|
manufacturer | Shantha Biotechnics Private Ltd. |
country-of-manufacture | India |
pharmaceutical-form | Liquid |
package-size | 10 Dose |
route-of-administration | Intramuscular |
Contraindications | ShanTT should not be administered to persons showing signs of hypersensitivity or known history of hypersensitivity to previous doses of Tetanus toxoid containing vaccines. Vaccination should be delayed in events of acute febrile illness or other serious illness. Elective immunization procedures should be deferred in case of poliomyelitis outbreak. |
preservative | Thiomersal |